Examples of 'plasma half-life' in a sentence
Meaning of "plasma half-life"
Plasma half-life refers to the time it takes for the concentration of a substance in the blood plasma to decrease by half. This is commonly used in pharmacology and medicine to determine how long a drug remains in the body
How to use "plasma half-life" in a sentence
Basic
Advanced
plasma half-life
The plasma half-life of imipenem was one hour.
Guaifenesin has a plasma half-life of one hour.
The plasma half-life of cilastatin is approximately one hour.
Its duration of action is reflected by its plasma half-life.
Their plasma half-life is approximately three weeks.
Furthermore ranolazine also has a relatively short plasma half-life.
Its plasma half-life increases with the dose.
The depletion from tissues was consistent with the plasma half-life.
The plasma half-life for isoprenaline is approximately two minutes.
Guaifenesin has a typical plasma half-life of approximately one hour.
The plasma half-life of montelukast is slightly longer in the elderly.
In some embodiments the second and first plasma half-life are similar.
Plasma half-life is about six weeks after a single intramuscular injection.
Preferably the intrinsic plasma half-life of the polypeptide itself is increased.
A one-phase exponential decay curve fit was used to calculate the plasma half-life.
See also
Natural tPA has a plasma half-life of about six minutes or less.
In yet another aspect, the antidote is conjugated with a moiety to extend its plasma half-life.
An improvement in plasma half-life would bring significant benefit to the patient.
Another approach is to increase the intrinsic plasma half-life of the polypeptide itself.
The apparent plasma half-life of pentosan polysulfate sodium depends on the route of administration.
In volunteers with reduced renal function, the plasma half-life of cefotetan is prolonged.
Determination of the plasma half-life and placental transfer are performed by well established techniques.
The resulting PEGylated peptides demonstrated significantly increased plasma stability and prolonged plasma half-life in mice.
The mean elimination plasma half-life of mefloquine is between two and four weeks.
Some novel properties for facilitating purification and extending the plasma half-life time should be introduced.
Evidence suggests that the plasma half-life of vidarabine is increased in the presence of allopurinol.
The present invention overcomes the problems associated with delivering a compound that has a short plasma half-life.
From the second phase, the terminal plasma half-life of a DARPin can be determined.
The plasma half-life is prolonged if the patient is suffering from liver and renal insufficiency.
Examples on the determination of terminal plasma half-life are given in the Examples.
The mean plasma half-life of a sedative-hypnotic compound may be determined using well known techniques.
PEGylation may improve the solubility and plasma half-life of a peptide.
The plasma half-life of angiotensin II administered intravenously is less than one minute.
The PEG moiety is conjugated to octocog alfa to increase the plasma half-life.
The effect of glycosylation on plasma half-life and protein activity has also been extensively studied.
Apparent volume of distribution, clearance and plasma half-life.
Indocyanine green has a very short plasma half-life and is rapidly taken up by the liver D.
The plasma half-life of perindopril is equal to 1 hour.
Such modification allows an increasing of the plasma half-life time of the original PHC molecule.
The plasma half-life is about five days.
Determination of the Plasma Half-Life of GDXa and Xa.
The plasma half-life of levetiracetam in adults is about 6 to 8 hours.
Salicylic acid in DuoPlavin has a plasma half-life of approximately 2 hours.
The mean plasma half-life of lumiracoxib is approximately 4 hours.
The half-life is preferably a human serum or plasma half-life.
The terminal plasma half-life is approximately 2 weeks in dogs.
Note that biological half-life is different than plasma half-life.
The steady state plasma half-life of eflornithine was approximately 8 hours.
Temoporfin is a low clearance substance with a terminal plasma half-life of 65 hours in patients.
It has a short plasma half-life of about 1h after parenteral administration.
You'll also be interested in:
Examples of using Plasma
Show more
Plasma concentrations are similar in males and females
Operating the plasma display basic operations
Plasma concentrations were quantifiable in all the patients
Examples of using Half-life
Show more
The half-life was prolonged in these patients
There is no change in half-life during treatment
Each elimination phase determines a half-life
